Article
Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease.
Infection and immunity - 14 Jul 2026
Kumaresan Venkatesh, Smith Trever C, Lumbreras Miranda, MacMackin Ingle Taylor, Kilgore Nathan, Starling-Lin Jolie F, Horn Elizabeth J, Seshu J
Abstract excerpt
Lyme disease (LD), caused by Borrelia burgdorferi (Bb), is the most common vector-borne disease in the United States. Novel strategies to control transmission of Bb to humans via ticks are critical for the prevention of LD. One such strategy is to leverage non-infectious mutant strains of Bb for pathogen-derived biologics to block Bb transmission during the natural infectious cycle. Deletion of Borrelia...
Topics
Join the communities discussing this publication.
